Summary: Rubella neutralization and haemagglutinininhibition tests were used to determine the incidence of rubella antibodies in the sera of 235 children and adolescents aged 1 month to 20 years. The tests showed good agreement in the detection of rubella antibodies resulting from acute infection. Maternal antibodies became undetectable within six months after birth. The proportion of children possessing rubella antibodies was found to be about 23% by the age of 5 years, rising sharply to 80% in the 6-12 years age group and 83% in the 13-20 years age group. Results indicate that the incidence of rubella infection may be higher in females than in males. The correlation between statements concerning a past history of rubella and immune status was poor, particularly in the older age groups. Any policy for vaccination against rubella must take into account the difficulties of identifying nonimmune persons in a large population.
Introduction
The use of the rubella neutralization test and the haemagglutinininhibition test has resulted in the accumulation of much information about the immune status of normal populations. Because of the risk of fetal abnormalities following infection with rubella virus during early pregnancy many such antibody surveys have been concerned with women of child-bearing age (Public Health Laboratory Service, 1968 ;  Vesikari, Vaheri, and Kauppinen, 1968) . More recently, the incidence of rubella antibodies in younger age groups has also been reported (Enders-Ruckle and Lindemann, 1969;  Chagnon, Davignon, and Pavilanis, 1969) . It seems likely that rubella vaccines will soon be available and the optimal age for their administration will have to be decided. Before such a decision can be made, knowledge of the immune status of the population of all age groups is essential.
This report presents the results of an investigation of the incidence of rubella neutralizing and haemagglutinin-inhibiting antibodies in children living in and around the city of Lee('. At the same time a comparison was made of the effectiveness of the two tests for the detection of rubella antibody. Asterisk indicates number of sera tested in each group. the 51 sera from children and adolescents of the 13-20 years age group H.A.I. antibody was found in 42 (82 4%) and V.N. antibody in 43 (84-3%).
A comparison was made between the H.A.I. and V.N. antibody titres of sera from 179 children over the age of 1 year -that is, those in which the rubella antibodies detected were presumed to be the result of postnatal infection. H.A.I. antibody titres were usually considerably higher than the corresponding V.N. antibody titres (Fig. 2) The results of this study confirm previous reports (Sever et al., 1965 ) that rubella occurs mainly among children of primary school age, though infants below the age of 5 years may be infected more often than was believed on clinical grounds (Dudgeon, 1967) . The particularly high level of immunity in Leeds children of the 6-12 years age group is :nteresting in view of an earlier study of the normal adult female population of the same area (P.H.L.S., 1968). Neutralizing antibody to rubella was found in 96% of these women, and it now appears that infection was acquired in most cases during childhood. The higher degree of immunity of the Leeds population compared with that of London, for example (80% level of immunity), is difficult to explain (P.H.L.S., 1968), but such variations are probably at least partly due to sociological differences between the communities investigated.
The data presented in Table I seem to indicate a difference in the frequency of rubella infection according to sex. In each of the three age groups the incidence of sero-immunity in females was consistently higher than that in males. This is in agreement with the reports of Hillenbrand (1956) and Watson and McDonald (1963) , which described higher incidences of clinical rubella among females compared with males. However, the numbers of sera involved in our study are small and subject to sampling errors. The study by Enders-Ruckle and Lindemann (1969) , involving a much larger number of sera, showed no significant over-all difference in immune status between the sexes.
It is confirmed that little reliance can be placed on statements concerning a past history of rubella. In this series about one-third of all firm statements were proved to be wrong on subsequent laboratory investigation. The histories, mostly obtained from parents, were most accurate for the 1-5 years age group. Similar findings have been reported by other workers (Vesikari et al., 1968) . This lack of correlation between statements concerning a past history of rubella and serological studies may be ascribed to the difficulty in diagnosis of rubella which is often simulated clinically by other infections (Krugman, 1965) . Ignorance of infection may also be due partly to the occurrence of subclinical attacks, and, to a certain extent, failure to remember the occurrence of clinical infection many years in the past.
The results of this and previous serological studies of children seem to raise a number of important problems concerning vaccination against rubella. Several vaccines have been developed and the results of preliminary clinical trials published (Proceedings of the 23rd Symposium on Microbiological Standardization, Rubella Vaccines, 1969) . Before these vaccines become freely available the age at which they are to be administered must be decided. As yet, insufficient data have been published concerning the possible transmission of vaccine strains of rubella virus across the placenta and the teratogenic effects of these strains on the fetus. Consequently, the vaccination of adult women will involve the prevention of pregnancy immediately before and after administration of the vaccine. If children are to be vaccinated, it must be taken into consideration that the majority are already naturally immune by the age of 10-15 years, and mass vaccination at this stage may be regarded as impracticable or uneconomical. The selection of children on the basis of past histories cannot be relied on, and the alternative screening of all children to detect immune status prior to vaccination would be very laborious. The vaccination of infants below the age of 5 years may be more logical, as this age group has the lowest level of natural immunity. In this case, however, vaccine-induced immunity may not be sufficient to afford protection into adulthood, and it may be necessary to revaccinate in later years.
Optimal antibiotic regimens for chronic recurrent mucopurulent bronchitis are difficult to assess, being complicated by the plethora of antibiotics available. It is still uncertain whether patients on chemoprophylaxis during the winter months fare better than those receiving prompt treatment of acute exacerbations. Further, can the lung function of these patients be preserved better by chemoprophylaxis ?
The British Tuberculosis Association (1960) report on chemotherapy in chronic bronchitis compared the effect of tetracycline 250 mg. b.d. with penicillin V potassium 312 mg. b.d. and a placebo in 226 patients. Treatment with penicillin or tetracycline reduced the loss of working days by about half compared with the controls. Neither drug significantly reduced the number of exacerbations, but both reduced their duration. The British Tuberculosis Association (1961) reported 519 patients who received in regimen A maintenance starch capsules with intermittent oral penicillin for exacerbations; B, maintenance tetracycline with starch capsules for exacerbations; C, maintenance penicillin with again starch capsules for exacerba-
